---
layout: minimal-medicine
title: Lapatinib
---

# Lapatinib
### Generic Name
Lapatinib

### Usage

Lapatinib is a targeted therapy primarily used in the treatment of advanced or metastatic breast cancer.  Its effectiveness hinges on the presence of human epidermal growth factor receptor 2 (HER2) overexpression in the cancer cells.  It's crucial to understand that lapatinib is not a standalone treatment; it's always used in combination with other medications.

Specifically, lapatinib is approved for use in the following scenarios:

* **In combination with capecitabine:** For patients with HER2-overexpressing metastatic breast cancer who have already received treatment with an anthracycline, a taxane, and trastuzumab. This means it's used after other standard treatments have been tried.

* **In combination with letrozole:** For postmenopausal women with HER2-overexpressing, hormone receptor (HR)-positive metastatic breast cancer, where hormone therapy is considered appropriate.  This combination targets both the HER2 pathway and hormone-dependent growth of the cancer.

While not formally approved for all of these uses, lapatinib is sometimes used off-label in other situations, including:

* **First-line treatment (off-label):** In some cases, doctors might use lapatinib in combination with capecitabine as a first-line treatment for HER2-positive metastatic breast cancer, even before other standard treatments.

* **Treatment after trastuzumab failure (off-label):** Lapatinib may be used in combination with trastuzumab in patients whose cancer has progressed despite prior treatment with trastuzumab. This indicates a role in overcoming resistance to trastuzumab.  

It is important to note that off-label uses should only be considered under the guidance of a qualified oncologist, as there is less established evidence supporting their effectiveness and safety compared to approved applications.


### Dosage

Lapatinib dosage varies depending on the specific combination therapy and the patient's individual health.  It's always administered orally (as tablets).

* **Metastatic Breast Cancer (HER2+ in combination with capecitabine, after prior therapies):** The usual dose is 1250 mg (five 250 mg tablets) once daily.

* **Metastatic Breast Cancer (HER2+, HR+, postmenopausal, in combination with letrozole):** The usual dose is 1500 mg (six 250 mg tablets) once daily.

* **Dosage Adjustments:**  Dosage adjustments are often necessary based on factors such as liver function, kidney function, and the severity of side effects.  For example, patients with severe liver impairment might require a lower dose.  Healthcare professionals will monitor patients closely and make adjustments as needed.  

* **Pediatric Use:** The safety and effectiveness of lapatinib in children have not been established.

### Side Effects

Common side effects (occurring in more than 10% of patients) include:

* Diarrhea
* Nausea
* Vomiting
* Fatigue
* Headache
* Rash
* Hand-foot skin reaction (palmar-plantar erythrodysesthesia)
* Changes in liver function tests

Less common but serious side effects include:

* Decreased left ventricular ejection fraction (heart problems)
* Severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis)
* Interstitial lung disease or pneumonitis (lung inflammation)
* Hepatotoxicity (liver damage)
* QT prolongation (heart rhythm abnormality)

Any new or worsening symptoms should be reported to a healthcare provider immediately.

### How it Works

Lapatinib is a type of tyrosine kinase inhibitor.  Tyrosine kinases are enzymes that play a crucial role in the growth and spread of cancer cells.  Lapatinib works by blocking the activity of two specific tyrosine kinases: EGFR (epidermal growth factor receptor) and HER2 (human epidermal growth factor receptor 2).  By inhibiting these kinases, lapatinib interferes with the cancer cell's signaling pathways, ultimately slowing down or stopping their growth.  This mechanism of action explains its effectiveness against HER2-overexpressing breast cancers.

### Precautions

* **Liver Impairment:**  Lapatinib should be used with caution in patients with liver problems, as it's primarily metabolized by the liver. Dosage adjustments may be necessary.

* **Heart Function:** Lapatinib can affect heart function.  Patients with pre-existing heart conditions or those who have received prior heart treatments (such as anthracyclines) should be carefully monitored.

* **Skin Reactions:**  Lapatinib can cause serious skin reactions. Patients should be aware of the signs and symptoms of these reactions and report them promptly.

* **Drug Interactions:** Lapatinib can interact with other medications, including some that prolong the QT interval (a measure of heart rhythm).  It's important to inform your doctor of all medications you are taking.

* **Pregnancy and Breastfeeding:** Lapatinib is categorized as pregnancy category D, meaning it poses a risk to the developing fetus.  Women of childbearing age should use effective contraception during treatment and for a week after the last dose.  Breastfeeding should be avoided during treatment and for a week after the final dose.


### FAQs

* **Q: How should I take lapatinib?** A:  Take lapatinib exactly as prescribed by your doctor.  It's usually taken once daily, on an empty stomach, at least one hour before or after eating.  Do not crush, chew, or break the tablets.

* **Q: What should I do if I miss a dose?** A: Take the missed dose as soon as you remember, unless it is almost time for the next dose. Do not take two doses at once to make up for a missed dose.

* **Q: Can I drink grapefruit juice while taking lapatinib?** A: No, it's best to avoid grapefruit juice while taking lapatinib, as it can interact with the medication and potentially increase its levels in your blood.

* **Q: How long will I need to take lapatinib?** A: The length of treatment depends on your response to the medication and your overall health. Your doctor will determine how long you should continue taking it.

* **Q: What should I do if I experience side effects?** A: Report any side effects, whether mild or severe, to your doctor or healthcare provider immediately.  They can advise you on how to manage these side effects or make necessary adjustments to your treatment plan.

**Disclaimer:** This information is intended for educational purposes only and does not provide medical advice.  Always consult with a healthcare professional before starting or changing any medication.  This information is not exhaustive and should not be considered a substitute for professional medical advice.
